Louis Jansen

1.1k total citations
22 papers, 432 citations indexed

About

Louis Jansen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Louis Jansen has authored 22 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Louis Jansen's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (11 papers). Louis Jansen is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (11 papers). Louis Jansen collaborates with scholars based in Netherlands, Germany and Canada. Louis Jansen's co-authors include Hendrik W. Reesink, R. Bart Takkenberg, A. de Niet, Neeltje A. Kootstra, F. Stelma, Karel A. van Dort, Valeska Terpstra, Peter L. M. Jansen, Joanne Verheij and Hans L. Zaaijer and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Louis Jansen

21 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis Jansen Netherlands 12 369 312 63 52 43 22 432
Mathieu Lefèvre France 6 177 0.5× 194 0.6× 51 0.8× 71 1.4× 18 0.4× 7 299
Issam Tout France 12 299 0.8× 253 0.8× 103 1.6× 80 1.5× 41 1.0× 15 429
Yong Kwang Park South Korea 11 209 0.6× 150 0.5× 48 0.8× 94 1.8× 24 0.6× 16 319
M Sidorkiewicz Poland 10 154 0.4× 217 0.7× 50 0.8× 93 1.8× 63 1.5× 29 337
Honglian Gui China 13 340 0.9× 306 1.0× 107 1.7× 55 1.1× 14 0.3× 27 494
Arleta Kowala‐Piaskowska Poland 12 203 0.6× 220 0.7× 109 1.7× 51 1.0× 14 0.3× 56 376
Zehui Yan China 11 253 0.7× 237 0.8× 64 1.0× 26 0.5× 11 0.3× 18 354
Shintaro Ogawa Japan 11 368 1.0× 334 1.1× 32 0.5× 69 1.3× 23 0.5× 32 446
Ranjit Chauhan Canada 14 682 1.8× 641 2.1× 20 0.3× 106 2.0× 83 1.9× 21 802
Ofer Ben‐Moshe Israel 7 206 0.6× 184 0.6× 46 0.7× 43 0.8× 7 0.2× 9 265

Countries citing papers authored by Louis Jansen

Since Specialization
Citations

This map shows the geographic impact of Louis Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Jansen more than expected).

Fields of papers citing papers by Louis Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Jansen. The network helps show where Louis Jansen may publish in the future.

Co-authorship network of co-authors of Louis Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Jansen. A scholar is included among the top collaborators of Louis Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Jansen. Louis Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Louis, et al.. (2024). Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors. Head & Neck. 47(1). 47–56.
2.
Spaan, Michelle, Krishna Mohan Agarwal, Özgür M. Koc, et al.. (2024). Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals. Clinical Gastroenterology and Hepatology. 23(11). 1964–1972.e4. 1 indexed citations
3.
4.
Jansen, Louis, et al.. (2024). Does the ChOLE classification relate to the duration of surgery?. European Archives of Oto-Rhino-Laryngology. 282(2). 789–795. 1 indexed citations
5.
Niet, A. de, Louis Jansen, F. Stelma, et al.. (2022). A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients. Journal of Clinical and Experimental Hepatology. 12(3). 735–744. 9 indexed citations
6.
Dort, Karel A. van, et al.. (2022). Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing. Viruses. 14(6). 1223–1223. 7 indexed citations
7.
Dort, Karel van, R. Bart Takkenberg, Louis Jansen, et al.. (2022). Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B. Hepatology. 76(1). 196–206. 16 indexed citations
8.
9.
Ree, Meike H. van der, Louis Jansen, Ad C. van Nuenen, et al.. (2017). Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients. The Journal of Infectious Diseases. 215(9). 1421–1429. 46 indexed citations
10.
Niet, A. de, Louis Jansen, F. Stelma, et al.. (2017). Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial. ˜The œLancet. Gastroenterology & hepatology. 2(8). 576–584. 36 indexed citations
11.
Willemse, Sophie B., Louis Jansen, A. de Niet, et al.. (2016). Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir. Antiviral Research. 131. 148–155. 15 indexed citations
12.
Stelma, F., Louis Jansen, Karel A. van Dort, et al.. (2016). HLA‐C and KIR combined genotype as new response marker for HBeAg‐positive chronic hepatitis B patients treated with interferon‐based combination therapy. Journal of Viral Hepatitis. 23(8). 652–659. 8 indexed citations
13.
Niet, A. de, F. Stelma, Louis Jansen, et al.. (2015). Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy. Journal of Hepatology. 64(3). 539–546. 32 indexed citations
14.
15.
Jansen, Louis, Andrew Vaillant, F. Stelma, et al.. (2015). O114 : Serum HBV-RNA levels decline significantly in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-CA. Journal of Hepatology. 62. S250–S250. 14 indexed citations
16.
Stelma, F., Andrew Vaillant, Louis Jansen, et al.. (2015). P0659 : Cytokine responses in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-Ca. Journal of Hepatology. 62. S567–S567. 1 indexed citations
17.
Stelma, F., A. de Niet, Louis Jansen, et al.. (2015). P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir. Journal of Hepatology. 62. S498–S498. 1 indexed citations
18.
Jansen, Louis, A. de Niet, F. Stelma, et al.. (2014). HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels. Journal of Hepatology. 61(4). 730–737. 16 indexed citations
19.
Bohte, Anneloes E., A. de Niet, Louis Jansen, et al.. (2013). Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. European Radiology. 24(3). 638–648. 76 indexed citations
20.
Niet, A. de, Louis Jansen, Hans L. Zaaijer, et al.. (2013). Experimental Hbsag/Anti-Hbs Complex Assay for Prediction of Hbeag Loss in Chronic Hepatitis B Patients Treated with Pegylated Interferon and Adefovir. Antiviral Therapy. 19(3). 259–267. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathieu Lefèvre Breakdown of academic impact, for papers by Issam Tout Breakdown of academic impact, for papers by Yong Kwang Park Breakdown of academic impact, for papers by M Sidorkiewicz Breakdown of academic impact, for papers by Honglian Gui Breakdown of academic impact, for papers by Arleta Kowala‐Piaskowska Breakdown of academic impact, for papers by Zehui Yan Breakdown of academic impact, for papers by Shintaro Ogawa Breakdown of academic impact, for papers by Ranjit Chauhan Breakdown of academic impact, for papers by Ofer Ben‐Moshe
Rankless by CCL
2026